• Pharma
  • January 7, 2025
  • 397 views
Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company

Zydus Lifesciences has announced a significant agreement with CVS Caremark, a CVS Health company, to include Zituvio™, Zituvimet™, and Zituvimet™ XR in its template formulary starting January 2025. These products,…